Dr. Bohm is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
17600 Shamrock Blvd
Westfield, IN 46074Phone+1 317-944-0980Fax+1 317-688-2985
Summary
- Dr. Matthew Bohm is a gastroenterologist in Westfield and Noblesville Indiana at Riverview Health. He received his medical degree from Philadelphia College of Osteopathic Medicine and has been in practice 10 years. He specializes in inflammatory bowel disease and is experienced in general gastroenterology, inflammatory bowel disease, ulcerative colitis, and crohn's disease.
Education & Training
Indiana University School of MedicineFellowship, Gastroenterology, 2011 - 2014
Temple University HospitalChief Residency, Internal Medicine, 2010 - 2011- Temple University HospitalResidency, Internal Medicine, 2007 - 2010
Philadelphia College of Osteopathic MedicineClass of 2007, DO
Certifications & Licensure
IN State License 2012 - 2025
NC State License 2023 - 2024
PA State License 2007 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Chief gastroenterology fellow Indiana university hospital, 2013
- Chief resident Temple university hospital, 2010
Publications & Presentations
PubMed
- 81 citationsDiagnosis and Management of Small Intestinal Bacterial OvergrowthMatthew Bohm, Robert M. Siwiec, John M. Wo
Nutrition in Clinical Practice. 2013-06-01 - 21 citationsThe Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.Amanda M Johnson, Maria Barsky, Waseem Ahmed, Samantha Zullow, Jonathan Galati
The American Journal of Gastroenterology. 2023-02-01 - 40 citationsShorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative ColitisDavid Faleck, Adam Winters, Shreya Chablaney, Preeti Shashi, Joseph Meserve
Clinical Gastroenterology and Hepatology. 2019-11-01
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumGursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
